CR11823A - Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenarativas e inflamatorias - Google Patents
Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenarativas e inflamatoriasInfo
- Publication number
- CR11823A CR11823A CR11823A CR11823A CR11823A CR 11823 A CR11823 A CR 11823A CR 11823 A CR11823 A CR 11823A CR 11823 A CR11823 A CR 11823A CR 11823 A CR11823 A CR 11823A
- Authority
- CR
- Costa Rica
- Prior art keywords
- compounds
- treatment
- degenarative
- pirazine
- fusioned
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Se describen nuevos compuestos de [1.2.4]triazol[1,5-a]pirazina e imidazo[1,2-a]pirazina que poseen una formula representada por las siguientes: Fórmula (Ia) o Fórmula (Ib)- Los compuestos se pueden preparar como composiciones farmacéuticas, y se pueden utilizar para la prevención y el tratamiento de una variedad de afecciones en mamíferos incluyendo los seres humanos, que incluye a modo de ejemplo no limitativo, dolor, inflamación, y otros.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12683308P | 2008-05-07 | 2008-05-07 | |
US14582709P | 2009-01-20 | 2009-01-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11823A true CR11823A (es) | 2011-03-16 |
Family
ID=40935606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11823A CR11823A (es) | 2008-05-07 | 2010-12-03 | Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenarativas e inflamatorias |
Country Status (20)
Country | Link |
---|---|
US (1) | US8012983B2 (es) |
EP (1) | EP2307426A1 (es) |
JP (1) | JP2011519897A (es) |
KR (1) | KR20110028445A (es) |
CN (1) | CN102036997A (es) |
AR (1) | AR071619A1 (es) |
AU (1) | AU2009245731A1 (es) |
BR (1) | BRPI0912412A2 (es) |
CA (1) | CA2723745A1 (es) |
CL (1) | CL2009001064A1 (es) |
CO (1) | CO6321159A2 (es) |
CR (1) | CR11823A (es) |
EA (1) | EA201071275A1 (es) |
IL (1) | IL209104A0 (es) |
MX (1) | MX2010011994A (es) |
PE (1) | PE20091880A1 (es) |
TW (1) | TW201002716A (es) |
UY (1) | UY31813A (es) |
WO (1) | WO2009135885A1 (es) |
ZA (1) | ZA201008759B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201120043A (en) * | 2009-11-05 | 2011-06-16 | Galapagos Nv | Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases |
JP6435323B2 (ja) * | 2013-06-19 | 2018-12-05 | ガラパゴス・ナムローゼ・フェンノートシャップGalapagos N.V. | 炎症性障害の治療のための新規化合物及びその医薬組成物 |
EP3137454A1 (en) | 2014-04-28 | 2017-03-08 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
KR20210141778A (ko) | 2016-06-07 | 2021-11-23 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
KR20220113545A (ko) | 2017-03-23 | 2022-08-12 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
CN108379583B (zh) * | 2018-03-27 | 2021-08-17 | 北京大学 | 一种肿瘤转移药物治疗的靶标及其应用 |
CN113967214A (zh) * | 2021-11-30 | 2022-01-25 | 广东药科大学 | 一种咪唑并吡嗪环丙烷甲酰胺类化合物的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6413776B1 (en) | 1998-06-12 | 2002-07-02 | Galapagos Geonomics N.V. | High throughput screening of gene function using adenoviral libraries for functional genomics applications |
US20020132823A1 (en) | 2001-01-17 | 2002-09-19 | Jiahuai Han | Assay method |
US7186832B2 (en) | 2003-02-20 | 2007-03-06 | Sugen Inc. | Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
US7893058B2 (en) * | 2006-05-15 | 2011-02-22 | Janssen Pharmaceutica Nv | Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
NZ573015A (en) * | 2006-05-31 | 2010-11-26 | Galapagos Nv | Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
US8133895B2 (en) | 2007-05-10 | 2012-03-13 | Janssen Pharmaceutica N.V. | Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
WO2008138842A1 (en) * | 2007-05-10 | 2008-11-20 | Galapagos N.V. | Imidazopyrazines and triazolopyrazine for the treatment of joint degenerative and inflammatory diseases |
-
2009
- 2009-05-04 CL CL2009001064A patent/CL2009001064A1/es unknown
- 2009-05-04 AR ARP090101598A patent/AR071619A1/es unknown
- 2009-05-06 EA EA201071275A patent/EA201071275A1/ru unknown
- 2009-05-06 EP EP09742103A patent/EP2307426A1/en not_active Withdrawn
- 2009-05-06 BR BRPI0912412A patent/BRPI0912412A2/pt not_active IP Right Cessation
- 2009-05-06 AU AU2009245731A patent/AU2009245731A1/en not_active Abandoned
- 2009-05-06 WO PCT/EP2009/055500 patent/WO2009135885A1/en active Application Filing
- 2009-05-06 KR KR1020107027298A patent/KR20110028445A/ko not_active Application Discontinuation
- 2009-05-06 CA CA2723745A patent/CA2723745A1/en not_active Abandoned
- 2009-05-06 US US12/436,219 patent/US8012983B2/en not_active Expired - Fee Related
- 2009-05-06 MX MX2010011994A patent/MX2010011994A/es not_active Application Discontinuation
- 2009-05-06 PE PE2009000625A patent/PE20091880A1/es not_active Application Discontinuation
- 2009-05-06 JP JP2011507918A patent/JP2011519897A/ja active Pending
- 2009-05-06 CN CN2009801163126A patent/CN102036997A/zh active Pending
- 2009-05-07 TW TW098115200A patent/TW201002716A/zh unknown
- 2009-05-07 UY UY0001031813A patent/UY31813A/es unknown
-
2010
- 2010-11-04 IL IL209104A patent/IL209104A0/en unknown
- 2010-12-03 CO CO10152830A patent/CO6321159A2/es not_active Application Discontinuation
- 2010-12-03 CR CR11823A patent/CR11823A/es not_active Application Discontinuation
- 2010-12-06 ZA ZA2010/08759A patent/ZA201008759B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2009135885A1 (en) | 2009-11-12 |
MX2010011994A (es) | 2010-11-30 |
UY31813A (es) | 2010-01-05 |
EA201071275A1 (ru) | 2011-06-30 |
PE20091880A1 (es) | 2009-12-28 |
CL2009001064A1 (es) | 2009-10-09 |
CN102036997A (zh) | 2011-04-27 |
CA2723745A1 (en) | 2009-11-12 |
US20090286798A1 (en) | 2009-11-19 |
US8012983B2 (en) | 2011-09-06 |
KR20110028445A (ko) | 2011-03-18 |
JP2011519897A (ja) | 2011-07-14 |
ZA201008759B (en) | 2011-08-31 |
EP2307426A1 (en) | 2011-04-13 |
IL209104A0 (en) | 2011-01-31 |
CO6321159A2 (es) | 2011-09-20 |
AR071619A1 (es) | 2010-06-30 |
TW201002716A (en) | 2010-01-16 |
BRPI0912412A2 (pt) | 2016-07-26 |
AU2009245731A1 (en) | 2009-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR10458A (es) | Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias | |
CR11823A (es) | Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenarativas e inflamatorias | |
CY1119813T1 (el) | Αλατα 2-φθορο-ν-μεθυλ-4-[7-(κινολιν-6-υλ-μεθυλ)-ιμιδαζο[1,2-β][1,2,4]τριαζιν-2-υλ]βενζαμιδιου και διαδικασιες που σχετιζονται με την παρασκευη αυτων | |
UY31198A1 (es) | Amidas de ácidos benzoicos triazinil sustituidos, composiciones farmacéticas conteniéndolos y aplicaciones. | |
EA201101243A1 (ru) | 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств | |
UY29469A1 (es) | Compuestos sulfoximino-macrocíclicos y sus sales, composiciones farmacéuticas que comprenden dichos compuestos, métodos de preparación y usos de los mismos. | |
CO6321259A2 (es) | Compuestos de 3h-[1,2,3]triazolo[4,5-d]pirimidina su uso como inhibidores de mtor quinasa y pi3 quinasa y su sintesis | |
ECSP088747A (es) | Pirazoles como inhibidores de la 11-beta-hsd1 | |
DOP2010000263A (es) | Derivados de imidazo-[1,2-b]-piridazina para el tratamiento de enfermedad mediada por cinasa de tirosina c-met | |
CL2011001360A1 (es) | Compuestos derivados de imidazol[1,2-a]pirazin-8-amina, inhibidores de tirosina quinasa esplenica; composicion farmaceutica que comprende un compuesto; uso de los compuestos en la preparacion de medicamentos para el tratamiento de trastornos alergicos, enfermedades autoinmunes y enfermedades inflamatorias; y metodo in vitro. | |
BRPI0510560A (pt) | pirido[2,3-d] pirimidin-7-onas pirrolil substituìdas e seus derivados como agentes terapêuticos | |
CR20110270A (es) | Piriloxi-indoles Inhibidores del VEGF-R2 y Uso de los Mismos para el Tratamiento de Enfermedades | |
CL2012000248A1 (es) | Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina. | |
CL2008003576A1 (es) | Compuestos derivados de amida del acido 6,7-dihidro-5h-imidazo[1,2-alfa]imidazol-3-carboxilico; composicion farmaceutica que los comprende; y usos en el tratamiento de una afeccion inflamatoria. | |
CL2007002708A1 (es) | Compuestos derivados de pirrolo[2,3-b]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, caquexia, trastornos inflamatorios, entre otros. | |
ECSP066770A (es) | Nuevos ésteres de quinuclidina cuaternizados | |
UY29343A1 (es) | Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso. | |
HN2008001666A (es) | Derivados acidos de cicloalquilamino | |
CL2008003472A1 (es) | Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias. | |
MA31630B1 (fr) | Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique | |
AR064152A1 (es) | Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion. | |
UA109796C2 (xx) | ПРОТИГРИБКОВІ 5,6-ДИГІДРО-4H-ПІРОЛО$1,2-a]$1,4]БЕНЗОДІАЗЕПІНИ І 6H-ПІРОЛО$1,2-a]$1,4]БЕНЗОДІАЗЕПІНИ, ЗАМІЩЕНІ БІЦИКЛІЧНИМИ ПОХІДНИМИ БЕНЗОЛУ | |
CL2008002060A1 (es) | Compuestos derivados de sulfonamida, inhibidores de la produccion de beta amiloide; metodo de preparacion; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento de enfermedades tales como alzheimer, angiopatia amiloide, sindrome de down, entre otras. | |
UY31805A (es) | Agonistas m1, composiciones farmacéuticas de los mismos, procesos para su preparacion y sus usos para el tratamiento del dolor | |
UY33010A (es) | Compuestos de pirazina fusionados como sus sales, útiles para el tratamiento de enfermedades degenerativas e inflamatorias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |